VIPR2

vasoactive intestinal peptide receptor 2, the group of Vasoactive intestinal peptide family receptors

Basic information

Region (hg38): 7:159028175-159144867

Links

ENSG00000106018NCBI:7434OMIM:601970HGNC:12695Uniprot:P41587AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the VIPR2 gene.

  • not_specified (50 variants)
  • not_provided (8 variants)
  • Myoepithelial_tumor (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the VIPR2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003382.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
2
clinvar
5
missense
48
clinvar
3
clinvar
1
clinvar
52
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 48 6 3
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
VIPR2protein_codingprotein_codingENST00000262178 13116784
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.72e-110.5701256820661257480.000262
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2832302420.9490.00001362821
Missense in Polyphen88103.330.851671214
Synonymous-0.2831121081.030.00000702860
Loss of Function1.352027.70.7230.00000156284

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007170.000716
Ashkenazi Jewish0.00009930.0000992
East Asian0.0001690.000163
Finnish0.00005220.0000462
European (Non-Finnish)0.0002640.000264
Middle Eastern0.0001690.000163
South Asian0.0003920.000392
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: This is a receptor for VIP as well as PACAP-38 and -27, the activity of this receptor is mediated by G proteins which activate adenylyl cyclase. Can be coupled to phospholipase C. {ECO:0000269|PubMed:8926282}.;
Pathway
cAMP signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class B Secretin-like;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Glucagon-type ligand receptors;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.167

Intolerance Scores

loftool
0.867
rvis_EVS
-0.62
rvis_percentile_EVS
17.31

Haploinsufficiency Scores

pHI
0.133
hipred
N
hipred_score
0.318
ghis
0.475

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.256

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Vipr2
Phenotype
growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; hematopoietic system phenotype; immune system phenotype;

Gene ontology

Biological process
signal transduction;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;cell-cell signaling;negative regulation of smooth muscle cell proliferation
Cellular component
plasma membrane;integral component of plasma membrane
Molecular function
G protein-coupled receptor activity;vasoactive intestinal polypeptide receptor activity;G protein-coupled peptide receptor activity;peptide hormone binding